Drug maker Eli Lilly strikes $375 million deal with US government for COVID-19 antibody treatment

(Natural News) American pharmaceutical firm Eli Lilly has agreed to supply the U.S. government with its experimental COVID-19 antibody medication. The company announced Oct. 28 that it will provide an initial 300,000 vials of the bamlanivimab antibody-drug amounting to $375 million, contingent on emergency use authorization (EUA) from the Food and Drug Administration (FDA). Eli...

from NaturalNews.com https://ift.tt/3ejinM0